Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

How accurate are stock forecasts?

Stock forecasts are based on technical and fundamental analysis but should not be considered as guaranteed predictions. Past performance does not guarantee future results.

How do I analyze COLL stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate COLL investment potential.

What is COLL stock price today?

Get real-time COLL stock price, historical data, and price charts on Financhill. Track COLL performance with our advanced analysis tools.

Is COLL a good investment?

Evaluate COLL investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy COLL stock?

To buy COLL stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of COLL?

View detailed market capitalization data and company valuation metrics for COLL on our comprehensive analysis page.

What is the P/E ratio of COLL?

Use our fundamental analysis tools to view COLL P/E ratio and compare valuation metrics with industry peers.

What are COLL earnings?

View COLL earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Collegium Pharmaceutical, Inc. Stock Predictions

Share Price Moved. Momentum Hasn't Slowed.

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi

Buy

COLL
Collegium Pharmaceutical, Inc.

Last Price:

$49.36

Seasonality Move:

7.64%

7 Day Trial

ALL ACCESS PASS

$ 7

14K Investors Got In Earlier. You Still Can.

Collegium Pharmaceutical, Inc. Stock Forecast

Over the next 52 weeks, Collegium Pharmaceutical, Inc. has on average historically risen by 10.4% based on the past 10 years of stock performance.
Collegium Pharmaceutical, Inc. has risen higher in 7 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 70%
Is Collegium Pharmaceutical, Inc. Stock Undervalued?

The current Collegium Pharmaceutical, Inc. [COLL] share price is $48.90. The Score for COLL is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
COLL is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.

Will Collegium Pharmaceutical, Inc. Stock Go Up Next Year?

Over the next 52 weeks, Collegium Pharmaceutical, Inc. has on average historically risen by 10.4% based on the past 10 years of stock performance.

Collegium Pharmaceutical, Inc. Stock Rating

Buy

Collegium Pharmaceutical, Inc. (COLL) is a Buy

Is Collegium Pharmaceutical, Inc. overpriced?

Collegium Pharmaceutical, Inc. has risen higher in 7 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 70%

Collegium Pharmaceutical, Inc. Stock Price History

Is COLL stock going to rise?

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and COLL is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Pharmaceuticals

Sector:

Health Care

Type:

stock

Website:

collegiumpharma.com

52-Week Data

52-Week High:

49.49

52-Week Low:

23.23

Prediction Charts

Market Cap:

1.5B

Price in USD:

48.90

Volume:

447.3K

Beta:

0.80

Technical Analysis

SMA50:

41.36

SMA100:

38.62

SMA200:

33.98

52-Wk Change:

58.25%

Stock Predictions

Is Collegium Pharmaceutical, Inc. stock public?

Yes, Collegium Pharmaceutical, Inc. is a publicly traded company.
What is the Collegium Pharmaceutical, Inc. stock quote today?

The Collegium Pharmaceutical, Inc. stock price is 48.90 USD today.
How to buy Collegium Pharmaceutical, Inc. stock online?

You can buy Collegium Pharmaceutical, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Nov-28	46.62	46.68	47.00	46.06
Dec-1	46.58	46.86	46.89	46.11
Dec-2	46.66	47.51	47.70	45.82
Dec-3	47.51	47.85	48.37	47.28
Dec-4	47.61	47.43	47.74	47.00
Dec-5	47.59	47.91	47.92	46.81
Dec-8	47.92	47.91	49.09	47.21
Dec-9	48.33	47.03	48.77	46.85
Dec-10	47.11	48.86	48.94	46.15
Dec-11	48.96	48.36	49.16	48.11
Dec-12	48.53	48.63	48.97	47.86
Dec-15	48.69	49.01	49.46	48.51
Dec-16	49.05	48.71	49.49	48.24
Dec-17	48.60	48.90	49.04	47.83

Collegium Pharmaceutical, Inc. Earnings

Collegium Pharmaceutical, Inc. Earnings Report: Per Share Collegium Pharmaceutical, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

Collegium Pharmaceutical, Inc. Forecast Revenue Growth

Collegium Pharmaceutical, Inc. Stock Analysis: Historical quarterly revenues per share for Collegium Pharmaceutical, Inc. and historical quarterly revenue growth:

Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.54 per share.

* Collegium Pharmaceutical, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.